title: Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation.
abstract: The effect of DSP-4, a neurotoxin selectively affecting the projections of the locus coeruleus, upon exploratory behaviour of rats was studied in a complex exploration test, including a choice between open and enclosed areas and both inquisitive and inspective exploration elements. One week after DSP-4 (50 mg/kg i.p.) administration, the neurotoxin-treated rats did not explore a novel open area to any extent on the first exposure to the apparatus; however, on the third day of testing, these animals began to explore the area and the novel objects. Diazepam (0.5 mg/kg) treatment did not change the behaviour of control rats, but significantly increased the exploratory activity of the DSP-4-treated animals. LY 288513, a selective CCKB receptor antagonist (0.01 mg/kg), prevented the increase in exploratory activity in the DSP-4-treated rats, but increased the exploratory activity of controls on the third exposure to the test situation. The results of this investigation suggest that DSP-4 treatment reduces neotic behaviour by increasing neophobia rather than by decreasing exploratory drive. The divergence reported between the relative potencies of CCKB receptor antagonists in exploratory activity and other anxiety tests may in part be due to the effects of these drugs on exploratory drive.
authors.affiliation: Department of Pharmacology, University of Tartu, Estonia.
authors.forename: J
authors.initials: J
authors.lastname: Harro
authors.forename: L
authors.initials: L
authors.lastname: Oreland
authors.forename: E
authors.initials: E
authors.lastname: Vasar
authors.forename: J
authors.initials: J
authors.lastname: Bradwejn
mesh_terms: D018663:Adrenergic Agents / Q000494:pharmacology*; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D001007:Anxiety / Q000523:psychology*; D001596:Benzylamines / Q000494:pharmacology*; D003975:Diazepam / Q000494:pharmacology; D005106:Exploratory Behavior / Q000187:drug effects*; D005260:Female; D006727:Hormone Antagonists / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000502:physiology*; D011720:Pyrazoles / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors; D012727:Sex Characteristics; D013563:Sympathectomy, Chemical
chemical_list: D018663:Adrenergic Agents; D014151:Anti-Anxiety Agents; D001596:Benzylamines; D006727:Hormone Antagonists; D011720:Pyrazoles; D011949:Receptors, Cholecystokinin; C074681:1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone; C012102:DSP 4; D003975:Diazepam; D009638:Norepinephrine